Smith, Shawna N.
Lanham, Michael
Seagull, F. Jacob
Dorsch, Michael
Errickson, Josh
Barnes, Geoffrey D. http://orcid.org/0000-0002-6532-8440
Funding for this research was provided by:
Agency for Healthcare Research and Quality (R18HS028562)
Article History
Received: 13 March 2023
Accepted: 21 April 2023
First Online: 15 May 2023
Declarations
:
: Protocol has been approved by the Michigan Medicine IRB (HUM00207165).
: Not applicable.
: Dr. Barnes discloses consulting for Pfizer, Bristol-Myers Squib, Janssen, Bayer, Boston Scientific, Abbott Vascular. Dr. Barnes serves on the Board of Directors for Anticoagulation Forum. All other authors have no competing interests.